Zai Lab is a China-based biotechnology firm that develops transformative medicines for the treatment of cancer, autoimmune and infectious diseases.
Business Model:
Revenue: $65.3M
Employees: 1,001-5,000
Address: 4560 Jinke Road
City: Pudong
State: shanghai municipality
Zip: 201210
Country: CN
Zai Lab is a China-based biotechnology firm that develops transformative medicines for the treatment of cancer, autoimmune and infectious diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
9/20/2017
IPO Valuation:
$1B
Ticker Symbol:
ZLAB
IPO Price:
$27.9/share
Amount Raised:
$158M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|